Womens Imaging

Mammo AI falls short to ultrasound in screening dense breasts
By Amerigo Allegretto
Mammography plus ultrasound yields better results than AI-enhanced mammography alone when it comes to screening of women with dense breasts.
July 23, 2024
Imaging in a 56-year-old woman with heterogeneously dense breasts (BIRADS C). (A) Left craniocaudal (left) and mediolateral oblique (right) digital mammograms show no abnormality. (B) Left craniocaudal (LCC, top) and left mediolateral oblique (LMLO, bottom) mammograms with retrospectively applied AI (Lunit Insight MMG, version 1.1.7.1; Lunit) show the lesion was given abnormality scores of 97% and 71%, respectively. The color bar indicates pixel-level abnormality scores corresponding to heatmap contour lines. Breast ultrasound performed the same day was considered negative (not shown). (C) Left craniocaudal (left) and mediolateral oblique (right) digital mammograms acquired nine months later show an irregular mass (arrows) in the left breast, which correlates with the heatmap areas scored as 97% and 71% by AI in the earlier screening mammogram (B). The radiopaque round marker denotes the site of the palpable abnormality indicated by the patient. (D) Transverse ultrasound imaging shows an irregular mass (arrow) in the left breast. The patient was treated with breast-conserving surgery, and the mass was proven to be invasive lobular carcinoma. Image courtesy of the RSNA.
How radiologists can image pregnant women post Dobbs decision
By Amerigo Allegretto
Standardized guidelines can help radiologists navigate the legal landscape of imaging pregnant women with ionizing radiation.
July 19, 2024
Ultrasound Sonographer Social
More women self-scheduling diagnostic mammograms
By Amerigo Allegretto
Online self-scheduling could increase adherence to diagnostic mammography.
July 16, 2024
Check Mark
Women delay breast screening after learning of pros and cons
By Amerigo Allegretto
Women in their 40s may delay breast cancer screening with mammography after learning about the exam's pros and cons.
July 15, 2024
Breast Screening Mammo
Cryoablation safe and effective for treating breast cancer
By Amerigo Allegretto
Cryoablation is a safe, effective treatment method for breast cancer, new research suggests.
July 11, 2024
Breast Cancer 3 D
CEM more efficient, comparably accurate to conventional mammography
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) may be an efficient diagnostic workup method for women undergoing breast cancer screening who have been recalled.
July 10, 2024
Contrast Injector 400
Black women less likely to undergo preoperative breast MRI
By Kate Madden Yee
Black women diagnosed with breast cancer are less likely than their white counterparts to undergo preoperative MRI, researchers report.
July 10, 2024
Mri Breast Cancer
Many women unaware of treatment options for uterine fibroids
By Amerigo Allegretto
Over 50% of women diagnosed with uterine fibroids have been offered hysterectomy, while fewer than 20% are presented with other options.
July 9, 2024
Uterus Pelvic Social
AI increases breast MRI's cancer detection 4-fold
By Amerigo Allegretto
An AI approach for supplemental breast MRI is about four times more efficient at detecting breast cancers than traditional methods.
July 9, 2024
(A) Case A was a 13-mm large BI-RADS 4 finding on MRI that corresponded to a 13-mm large invasive cancer as diagnosed in the surgical specimen. (B) Case B was a 9-mm large BI-RADS 4 finding on MRI that corresponded to an 8-mm invasive cancer and 14-mm ductal cancer in situ. (C) Case C was three suspicious lesions within a total area of 60 mm, BI-RADS 5 finding on MRI, that corresponded to a 50-mm multifocal invasive lobular cancer. (D) Case D was two suspicious lesions, the largest 13 mm, BI-RADS 3 on MRI, which corresponded to a 10-mm invasive lobular cancer with 85-mm extent including ductal cancer in situ. Images courtesy of Nature Medicine. Licensed under CC BY 4.0.
The rise of theranostics: Part 4 -- Women's theranostics on the horizon
By Liz Carey
SNMMI women's theranostics track rounds up research in CAM-HER2 therapy safety, Ga-68-NeoB PET imaging, FES PET/CT for novel patient population, and CXCR4-targeted imaging.
July 8, 2024
Adobe Stock 822401969 Women Woman Abstract
Breakthroughs in cancer breast screening technologies
By Erik Anderson
Erik Anderson of women's imaging vendor Hologic discusses the impact of recent technological advances for detecting and diagnosing breast cancer.
July 5, 2024
Erik Anderson thumb
Imaging societies, advocates continue railing against Braidwood ruling
By Amerigo Allegretto
Imaging societies and cancer screening advocates continue to criticize a recent federal ruling that challenges no-cost preventive health services.
July 1, 2024
Gavel3
Page 1 of 676
Next Page